Acorda Therapeutics Inc Debt/Equity
What is the Debt/Equity of Acorda Therapeutics Inc?
The Debt/Equity of Acorda Therapeutics Inc is -1.69
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on NASDAQ compared to Acorda Therapeutics Inc
What does Acorda Therapeutics Inc do?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Companies with debt/equity similar to Acorda Therapeutics Inc
- ProStar has Debt/Equity of -1.69
- Mobile Internet (China) has Debt/Equity of -1.69
- Prakash Steelage has Debt/Equity of -1.69
- Pinehurst Capital I has Debt/Equity of -1.69
- Generation Mining has Debt/Equity of -1.69
- YDx Innovation has Debt/Equity of -1.69
- Acorda Therapeutics Inc has Debt/Equity of -1.69
- Nostrum Oil & Gas Plc has Debt/Equity of -1.69
- Fragrant Prosperity has Debt/Equity of -1.68
- Memex has Debt/Equity of -1.68
- Intelgenx Technologies Corp has Debt/Equity of -1.68
- IntelGenx Technologies has Debt/Equity of -1.68
- Kane Biotech has Debt/Equity of -1.68